Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $255.9752W HIGH $461.62
Volume
3.74 M
Value Traded
1.30 B
Short % Float
1.56%
Days to Cover
2.1
-2.12%Week
+8.62%1 Month
-4.29%3 Month
+11.89%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
368.36 B
EPS (TTM)
15.73
P/E Ratio
26.08
Ent. Value
406.40 B
Total Shares
897.59 M
Float Shares
895.45 M
Insiders
0.24%
Institutions
90.25%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | Small Molecule | Oncology | - |
PoA blends historical approval base rates, trial design score and FDA review track record.
UNH Catalyst Timeline
Dated clinical, regulatory and corporate events for UNITEDHEALTH GROUP INCORPORATED (Delaware)
Past FDA Catalysts and PDUFA Decisions
How UNH actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| - | Example Drug | Phase 3 data readout | Phase 3 |
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
UNITEDHEALTH GROUP INCORPORATED (Delaware) is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every UNH program
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Conway Patrick HughOfficer (Chief Executive Officer, Optum) | Sell | -1,169 15,327.797 held | $390.00 | 08/21/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in UNH
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 1.2 % (-53.8 %) | 66.96 M | 161.10 K | -52.1% ( -175.20 K) |
UNH Institutional Ownership Trends
UNH Short Interest
Shares sold short, counted twice a month.
1.56%
Short % of Float
of tradable shares sold short
14.0M
Shares Sold Short
-12.2% vs prior count
2.1 Moderate
Days to Cover
trading days of normal volume to buy every short share back
6.8M
Avg Daily Volume
the average used for days to cover
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-30 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How UNH ranks across every disease it competes in
Competitive Position is a premium feature
See how UNH ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialUNH News
-UNH
Oct 27, 2026▼ -0.2%today
Beyond Claims Data: Codoxo and UnitedHealth Group to Present Innovative Strategies for Uncovering Healthcare Fraud at NHCAA 2026
Codoxo will present strategies for detecting healthcare fraud at the NHCAA Annual Training Conference. The session will emphasize using complementary data sources beyond claims data to identify overlooked fraud patterns. This approach aims to enhance investigative leads for payers in the healthcare sector.
Read more →-UNH
Oct 22, 2026UnitedHealthcare to Support Northeast Missouri Health Council Efforts to Sustain and Expand Rural Maternal Healthcare
UnitedHealthcare announced a $540,000 investment to support the Northeast Missouri Health Council. This funding aims to sustain and expand access to obstetrics and gynecology services in rural areas. The initiative will stabilize the current workforce, recruit new providers, and develop a residency pathway for OB-GYN.
Read more →-UNH
Oct 13, 2026UnitedHealth Group Reports Third Quarter 2026 Results
UnitedHealth Group has reported its third quarter results for 2026, showcasing strong performance and an optimistic outlook. The company has raised its guidance for the full year 2026, reflecting confidence in its operational execution. CEO Stephen Hemsley emphasized the commitment to enhancing patient and clinician experiences.
Read more →-UNH
Oct 1, 2026UnitedHealthcare 2027 Medicare Plans Focus on Affordability, Simplicity and a More Connected Healthcare Experience
UnitedHealthcare has launched its 2027 Medicare Advantage plans aimed at enhancing affordability, simplicity, and connectivity in healthcare. The new plans cater to a diverse population of beneficiaries, emphasizing personalized care and accessibility. This initiative reinforces UnitedHealthcare's position as a leading Medicare provider for 18 consecutive years.
Read more →-UNH
Sep 24, 2026UnitedHealth Group Announces Addition to Leadership Team
UnitedHealth Group has appointed Jodee Kozlak as chief administrative officer, effective September 28, 2026. This newly created position aims to drive enterprise modernization and alignment across the company's various sectors. Kozlak will oversee areas including People, Real Estate, Procurement, and Corporate Security, leveraging her extensive experience in business strategy.
Read more →-UNH
Sep 15, 2026UnitedHealth Group Announces Earnings Release Date
UnitedHealth Group has announced that it will release its financial results for the third quarter of 2026 on October 13, 2026, prior to the market opening. This announcement reflects the company's commitment to keeping stakeholders informed about its financial performance.
Read more →-UNH
Aug 28, 2026AM Best Affirms Credit Ratings of UnitedHealth Group Incorporated and Its Subsidiaries
AM Best has affirmed the credit ratings of UnitedHealth Group and its subsidiaries, indicating strong financial stability. The Long-Term Issuer Credit Rating is rated 'a-' (Excellent), while the Financial Strength Rating for its health and dental insurance subsidiaries is rated 'A' (Excellent). This reflects the company's robust performance in the insurance sector.
Read more →-UNH
Aug 18, 2026UnitedHealthcare Expands Access to Child and Family Behavioral Coaching to 13 Million Commercial Members
UnitedHealthcare has announced the expansion of its child and family behavioral coaching program to approximately 13 million commercial members. This initiative aims to provide early behavioral health support for children, teens, and caregivers, focusing on low-severity behavioral health concerns. The expansion is a response to growing interest from employers and families seeking such services.
Read more →-UNH
Aug 12, 2026UnitedHealth Group Board Authorizes Payment of Quarterly Dividend
UnitedHealth Group's board has approved a quarterly cash dividend of $2.32 per share. This payment will be made to shareholders on September 22, 2026, for those on record by September 14, 2026. This decision reflects the company's ongoing commitment to returning value to its shareholders.
Read more →-UNH
Jul 29, 2026UnitedHealth Group Partners with UT Health Sciences to Expand Health Hubs to More Communities Across Tennessee
UnitedHealth Group has announced a $4 million commitment to expand the University of Tennessee Health Sciences' health hub model across Tennessee. This initiative will increase the number of health hubs from five to thirteen, enhancing access to preventive care and chronic condition support for local communities. The expansion aims to improve health resources available to Tennesseans.
Read more →-UNH
Jul 16, 2026UnitedHealth Group Reports Second Quarter 2026 Results
UnitedHealth Group reported its second quarter 2026 results, showcasing progress in operational simplification and enhancing patient care. The company has raised its guidance for the full year 2026, reflecting a positive outlook. CEO Stephen Hemsley emphasized the commitment to affordability and improved healthcare experiences through modern technology.
Read more →-UNH
Jul 9, 2026UnitedHealthcare Launches New Spending Account Benefit, Putting More Choice in the Hands of Consumers
UnitedHealthcare has launched a new Lifestyle Spending Account (LSA) to provide employers with a flexible benefit that supports employees' health and well-being. This account allows employees to personalize their health experiences and shop for products and services that complement existing benefits. The LSA is integrated with the UHC Store for enhanced accessibility.
Read more →-UNH
Jun 30, 2026UnitedHealthcare Community Plan of Nebraska Invests $385,000 to Expand Programs to Support Older Adults, Caregivers and People with Disabilities
UnitedHealthcare Community Plan of Nebraska has announced a $385,000 investment aimed at expanding programs to support older adults, caregivers, and individuals with disabilities. This initiative reflects the company's commitment to enhancing community health services. The funding will likely facilitate improved access to resources for these populations.
Read more →-UNH
Jun 3, 2026UnitedHealth Group Updates on Annual Shareholder Meeting, Board Actions
UnitedHealth Group has provided an update regarding its annual shareholder meeting and board actions. The details shared are limited, focusing on procedural aspects rather than specific outcomes or changes. This announcement does not indicate any significant developments or shifts in strategy at this time.
Read more →-UNH
Apr 21, 2026▲ +7%on this news
UnitedHealth Group Reports First Quarter 2026 Results
UnitedHealth Group reported strong first quarter results for 2026, with revenues of $111.7 billion and adjusted net earnings per share of $7.23. The company is focusing on simplifying healthcare and enhancing consumer experiences, supported by significant investments in technology. However, it faced challenges such as increased operating costs and a decline in Medicare Advantage enrollment. The company also announced plans to acquire Alegeus Technologies and repurchase $2 billion of its common stock.
Read more →-UNH
Oct 28, 2025UnitedHealth Group Reports Third Quarter 2025 Results and Raises Full Year 2025 Earnings Outlook
UnitedHealth Group reported robust third quarter 2025 results with revenues increasing by 12% year-over-year to $113.2 billion and earnings per share adjusted to $2.92. The company raised its full year earnings forecast, now expecting adjusted earnings of at least $16.25 per share. Despite these growth indicators, earnings from operations saw a significant decline of 50% compared to the previous year, and the net margin decreased to 2.1%. Challenges were noted in operating margins, attributed to elevated medical costs and ongoing Medicare funding impacts.
Read more →-UNH
Jul 31, 2025▼ -6.2%on this news
UnitedHealth Group Announces Changes to Leadership Team (
UnitedHealth Group has announced the appointment of Wayne S. DeVeydt as CFO, effective September 2, 2025, replacing John F. Rex who will take on a strategic advisory role. DeVeydt, who has a significant background in healthcare finance, previously held leadership positions at Bain Capital and Surgery Partners. The transition is anticipated to enhance the company's vision and operational efficiency, with Rex remaining involved in advisory capacities.
Read more →-UNH
Jul 29, 2025▼ -7.5%on this newsshared move
UnitedHealth Group Re-Establishes Full Year Outlook and Reports Second Quarter 2025 Results
UnitedHealth Group has revised its 2025 outlook, now projecting revenues between $445.5 billion and $448.0 billion and earnings per share of at least $14.65. In its second quarter report, the company announced earnings of $3.74 per share, with adjusted earnings at $4.08. Despite the positive growth indicators, the company also acknowledged rising medical costs contributing to an increased medical care ratio, which has posed challenges to its financial performance. Overall, the company expresses confidence in regaining earnings growth potential by 2026.
Read more →-UNH
May 13, 2025▼ -17.8%on this news
UnitedHealth Group Announces Leadership Transition Stephen J. Hemsley named Chief Executive Officer
UnitedHealth Group has announced the appointment of Stephen J. Hemsley as CEO following Andrew Witty's resignation for personal reasons. The company, which expects to return to growth in 2026, has suspended its 2025 outlook due to rising medical expenditures and unexpectedly high costs associated with new Medicare Advantage beneficiaries. This leadership transition occurs during a time of accelerated care activity and an expansion of benefit offerings. Hemsley, who previously served as CEO, returns to lead the company amidst these challenges.
Read more →About UNITEDHEALTH GROUP INCORPORATED (Delaware)
Headquarters1 HEALTH DRIVE, EDEN PRAIRIE, MN, 55344
BIOPHARMAWATCH ELITE PLUS
Trade the next UNH catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime